ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -1.6% | 31 | 0.0% | 0.00% | – |
| Q2 2023 | $63 | +1.6% | 31 | 0.0% | 0.00% | – |
| Q1 2023 | $62 | -59.5% | 31 | -52.3% | 0.00% | – |
| Q4 2022 | $153 | – | 65 | +109.7% | 0.00% | – |
| Q3 2022 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 31 | -46.6% | 0.00% | – |
| Q4 2021 | $0 | – | 58 | -44.8% | 0.00% | – |
| Q3 2021 | $0 | – | 105 | +238.7% | 0.00% | – |
| Q2 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 31 | -27.9% | 0.00% | – |
| Q2 2020 | $0 | – | 43 | +38.7% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 31 | -22.5% | 0.00% | – |
| Q2 2019 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SG3 Management, LLC | 100,000 | $249,000 | 0.03% |
| Murchinson Ltd. | 50,593 | $126,000 | 0.02% |
| Marquette Asset Management, LLC | 17,318 | $43,000 | 0.01% |
| SG3 Management, LLC | 22,706 | $57,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $117,000 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $81,000 | 0.00% |
| BAILARD, INC. | 35,000 | $87,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 131,501 | $327,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,238 | $25,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 882,900 | $2,198,000 | 0.00% |